Normal view MARC view ISBD view

Drénou, B

CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. [electronic resource] - Blood Apr 1997 - 2966-74 p. digital

Publication Type: Case Reports; Journal Article

ISSN: 0006-4971

Subjects--Topical Terms:
ATP Binding Cassette Transporter, Subfamily B, Member 1--analysis
Adult
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow Transplantation
CD3 Complex--analysis
CD56 Antigen--analysis
Cell Nucleus--ultrastructure
Cisplatin--administration & dosage
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Doxorubicin--administration & dosage
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Etoposide--administration & dosage
Fatal Outcome
Female
Femoral Neoplasms--drug therapy
Herpesvirus 4, Human
Humans
Idarubicin--administration & dosage
Immunophenotyping
Killer Cells, Natural--drug effects
Lymphoma, Large-Cell, Immunoblastic--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Lymphoma, T-Cell--drug therapy
Male
Methylprednisolone--administration & dosage
Neoplasm Invasiveness
Neoplasm Proteins--analysis
Neoplastic Stem Cells--drug effects
Pelvic Neoplasms--drug therapy
Prednisone--administration & dosage
Quinine--administration & dosage
Vincristine--administration & dosage